Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew Fisher (Newcastle, United Kingdom). Current and future preventive and treatment strategies in CLAD. International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation

Member's Comments

No comment yet.

Related content which might interest you: How to make interventions more successful in the future Source: International Congress 2015 – PG13 Monitoring physical activity Year: 2015 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 The present and the future of vaccines and other preventive measures in the era of EID Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020 Recommended new therapies for severe asthma and the future Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Other options of prevention - the current state and the future Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Current strategies for managing CTEPH Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Population screening initiatives and future strategies Source: International Congress 2014 – Ceremony for the ERS COPD research Award 2014 - Symposium: Finding patients with COPD: how, when and where Year: 2014 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 Evaluation of the effectiveness of three different therapeutics modalities for tobacco cessation Source: Eur Respir J 2005; 26: Suppl. 49, 390s Year: 2005 Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020